Aurobindo Pharma gets FDA nod for injection to treat cancer
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.
Drugs
Pharma
Drugs
Medical
Pharma
Scientists use nanoparticle therapy to cure arthritis in mice
A nanoparticle treatment has "cured" mice that had a genetic arthritis condition, according to Scripps Research, a nonprofit US medical research institution.
Drugs
Medical
Pharma
Bharat Biotech’s nasal Covid vaccine to roll out this month
Bharat Biotech, an Indian developer of vaccines for infectious diseases, will roll out its nasal Covid-19 vaccine for patients above 18 years in.
Drugs
Health
Medical
Pharma
Uncategorized
India’s Marion Biotech under drug regulator’s scanner
Drug regulators started investigating Marion Biotech after Uzbekistan alleged 18 children died in Samarkand city following the consumption of cough syrup made by.
Drugs
Pharma
US court dismisses antitrust claims against Dr. Reddy’s cancer drug
A US court dismissed all claims against Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary, in an antitrust complaint related to the cancer drug.
Drugs
Medical
Pharma
China’s Everest starts first phase operations to make mRNA vaccines
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
Drugs
Medical
Pharma
83% of all Africans yet to receive a single Covid-19 vaccine dose
A third of the world’s population has still not received a single dose of the Covid-19 vaccine, including 83% of all Africans, according.
Drugs
Pharma
Indian regulator approves Aurobindo Pharma drug for lung, brain infections
The Indian drug regulator had given its nod for Tergene, a joint venture of Aurobindo Pharma, to make a vaccine to fight pneumonia,.
Drugs
Pharma
Advent to buy 50.1% stake in Suven Pharma for $762 million
Advent International, a global private equity investor, will buy a 50.1% stake in India’s Suven Pharmaceuticals for INR 63,130 million ($762 million), according.